DK0760394T3 - Mild Newcastle disease-virusvaccine - Google Patents

Mild Newcastle disease-virusvaccine

Info

Publication number: DK0760394T3
Authority: DK; Denmark
Prior art keywords: disease virus; newcastle disease; mild; virus vaccine; poultry
Prior art date: 1995-08-01

Application number

DK96202157T

Other languages

Danish (da)

English (en)

Inventor

Carla Christina Schrier

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-01

Filing date

1996-07-30

Publication date

2002-01-21

1996-07-30 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2002-01-21 Application granted granted Critical

2002-01-21 Publication of DK0760394T3 publication Critical patent/DK0760394T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Immunology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK96202157T 1995-08-01 1996-07-30 Mild Newcastle disease-virusvaccine DK0760394T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US50991495A	1995-08-01	1995-08-01

Publications (1)

Publication Number	Publication Date
DK0760394T3 true DK0760394T3 (da)	2002-01-21

Family

ID=24028630

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96202157T DK0760394T3 (da)	1995-08-01	1996-07-30	Mild Newcastle disease-virusvaccine

Country Status (11)

Country	Link
US (1)	US5750111A (fr)
EP (1)	EP0760394B1 (fr)
JP (1)	JP3945842B2 (fr)
AT (1)	ATE206754T1 (fr)
BR (1)	BR9603227A (fr)
CA (1)	CA2181862C (fr)
DE (1)	DE69615772T2 (fr)
DK (1)	DK0760394T3 (fr)
ES (1)	ES2165466T3 (fr)
MX (1)	MX9603124A (fr)
PT (1)	PT760394E (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA978434B (en) *	1996-09-27	1998-03-26	Akzo Nobel Nv	Inactivated vaccines.
CA2312626A1 (fr)	1999-07-27	2001-01-27	Akzo Nobel N.V.	Virus recombinant de la maladie de newcastle utilise pour vacciner les embryons
EP1074614B1 (fr) *	1999-07-27	2004-07-07	Akzo Nobel N.V.	Virus de la maladie de Newcastle recombinant pour la vaccination in ovo
US20030215455A1 (en) *	2002-05-14	2003-11-20	Bailey Reynolds	Vaccine stabilizer and method of use
TW200502402A (en) *	2002-12-06	2005-01-16	Wyeth Corp	Escape mutants of newcastle disease virus as marker vaccines
ES2322272T3 (es) *	2003-12-23	2009-06-18	Intervet International Bv	Vacuna de combinacion para aves de corral.
WO2006082588A2 (fr) *	2005-02-07	2006-08-10	Pharmalight Inc.	Procede et dispositif d'administration ophtalmique d'ingredients pharmaceutiquement actifs
WO2011067224A1 (fr) *	2009-12-01	2011-06-09	Intervet International B.V.	Vaccin inactivé pour volailles
CN112662633A (zh) *	2020-12-28	2021-04-16	中国水产科学研究院珠江水产研究所	II型草鱼呼肠孤病毒冷适应株GCRV-GD108ca及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2767117A (en) *	1953-10-22	1956-10-16	Crawley John Frederick	Poultry virus vaccine products and method of preparing the same
US4053583A (en) *	1976-03-01	1977-10-11	Smithkline Corporation	Live newcastle disease virus vaccines
BE853923A (fr) *	1977-04-25	1977-10-25	Rit Rech Ind Therapeut	Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
SU826584A1 (ru) *	1979-10-29	1982-11-07	Всесоюзный государственный научно-контрольный институт ветеринарных препаратов	Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
DE68918649T2 (de) *	1988-07-18	1995-03-23	Duphar Int Res	Lebende Newcastle-Krankheit-Virus-Vakzine.
US5250298A (en) *	1988-10-07	1993-10-05	University Of Delaware	Live attenuated newcastle disease virus vaccines and preparation thereof
HU203983B (en) *	1988-12-05	1991-11-28	Mta Allatorvostudomanyi Kutato	Process for producing living vaccine against fowlpox
US5118502A (en) *	1989-06-20	1992-06-02	The University Of Georgia Research Foundation, Inc.	Naturally attenuated newcastle disease vaccine and method of using the same
US5427791A (en) *	1992-08-05	1995-06-27	Regents Of The University Of Minnesota	Embryonal vaccine against Newcastle disease

1996
- 1996-07-23 CA CA002181862A patent/CA2181862C/fr not_active Expired - Lifetime
- 1996-07-30 BR BR9603227A patent/BR9603227A/pt not_active Application Discontinuation
- 1996-07-30 PT PT96202157T patent/PT760394E/pt unknown
- 1996-07-30 AT AT96202157T patent/ATE206754T1/de active
- 1996-07-30 EP EP96202157A patent/EP0760394B1/fr not_active Expired - Lifetime
- 1996-07-30 ES ES96202157T patent/ES2165466T3/es not_active Expired - Lifetime
- 1996-07-30 DE DE69615772T patent/DE69615772T2/de not_active Expired - Lifetime
- 1996-07-30 DK DK96202157T patent/DK0760394T3/da active
- 1996-07-31 MX MX9603124A patent/MX9603124A/es unknown
- 1996-08-01 JP JP20369296A patent/JP3945842B2/ja not_active Expired - Lifetime
1997
- 1997-01-10 US US08/781,436 patent/US5750111A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PT760394E (pt)	2002-04-29
MX9603124A (es)	1997-06-28
CA2181862A1 (fr)	1997-02-02
JPH09154572A (ja)	1997-06-17
DE69615772T2 (de)	2002-08-01
JP3945842B2 (ja)	2007-07-18
EP0760394A1 (fr)	1997-03-05
ATE206754T1 (de)	2001-10-15
ES2165466T3 (es)	2002-03-16
US5750111A (en)	1998-05-12
BR9603227A (pt)	1998-04-22
CA2181862C (fr)	2009-12-22
DE69615772D1 (de)	2001-11-15
EP0760394B1 (fr)	2001-10-10

Publication	Publication Date	Title
DK651689D0 (da)	1989-12-20	Oralt autoantigenholdigt praeparat
PT584348E (pt)	2005-10-31	Vacina genetica para virus da imunodeficiencia
EE9900343A (et)	2000-02-15	Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
DK1103564T3 (da)	2009-05-11	Cancerantigener baseret på tumorsuppressorgen WT1-produkt
FI871362L (fi)	1987-03-27	Virusvaccin.
ATE264691T1 (de)	2004-05-15	Newcastle-krankheitsvirus-kombinationsimpfstoff
FR2620459B1 (fr)	1992-07-24	Virus recombinant de la vaccine
DK0760394T3 (da)	2002-01-21	Mild Newcastle disease-virusvaccine
DE69738641D1 (de)	2008-05-29	Lebend-impfstoff gegen heliobacter pylori
NL300336I2 (nl)	2009-01-05	Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
PT744027E (pt)	2005-05-31	Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos
BR8707549A (pt)	1989-02-21	Vacina contendo antigenos de carrapato
DK0626008T3 (da)	2005-05-02	Vaccine, der som en adjuvans indeholder acemannan
FI875309L (fi)	1988-08-11	Konjugatvaccin.
GB2227936A (en)	1990-08-15	Vaccine against brucella abortus
DK0396193T3 (da)	1995-02-27	Hundekoronavirusvaccine
DK0623172T3 (da)	2005-04-25	Rekombinant Mareks sygdomsvirus-poxvirusvaccine
ATE112490T1 (de)	1994-10-15	Lebende newcastle-krankheit-virus-vakzine.
IT1276509B1 (it)	1997-10-31	Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
ITRM910385A0 (it)	1991-06-03	Vaccini utilizzanti eritrociti come veicoli di antigeni.
EP0496787A4 (en)	1993-04-28	Novel infectious bursal disease virus
BR9814556A (pt)	2000-10-17	Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas
ATE66818T1 (de)	1991-09-15	Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis.
CS578887A1 (en)	1989-10-13	Inactivated antigen of cattle's mucosal disease's virus
NO891355D0 (no)	1989-03-30	Vaksinasjon mot rabis-beslektede virus.